Off-Label Use of Drugs Draws Large Fines But Doesn't Deter Drug Manufacturers (6.7.10)

June 7, 2010
By Patton Law Practice on June 7, 2010 4:59 PM | | Comments (0)

In spite of recent significant off-label-use fines, Pfizer and Johnson & Johnson continue to condone off-label uses of their drugs to increase their overall profit.

For additional information, go to: Drugmakers continue 'off-label marketing' despite large fines

Leave a comment